Expo
ADLM
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry
Events
Webinars
- Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers
- Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis
- New Machine-Learning Equation Improves LDL Cholesterol Assessment
- Blood Biomarker May Signal Cognitive Decline Risk a Decade Before Symptoms
- Ultrasensitive Biosensor Detects Early Liver Fibrosis from Blood
- Blood Gene Expression Fluctuates More Than Expected Over Time
- Genomic Test Helps Early Breast Cancer Patients Avoid Chemotherapy
- Residual Disease Test Predicts Merkel Cell Carcinoma Recurrence Earlier Than Antibody Assay
- Portable Rapid Test Aims to Detect Ebola at Point of Care
- Point-of-Care Molecular Technology Promises Transformative Shift in Oncology
- New Marker Helps Detect Aggressive Multiple Myeloma Earlier
- New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
- AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
- Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
- Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
- New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
- Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis
- Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19
- Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance
- New Rapid Ebola Antigen Test Detects Infection at Point of Care
- Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
- Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
- Bacterial Growth Assay Predicts COVID-19 Severity From Plasma
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
- Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
- Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
- Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
- Seed Amplification Test Expands Access to Neurodegenerative Disease Testing
- Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk
- Immune Biomarkers Support Early Risk Stratification in Oral Precancer
- Global Genetic Map Identifies Regional Parkinson’s Variants to Support Diagnostics
- Breakthrough Genetic Map Advances Understanding of Bone Disorders
- Study Identifies Hereditary Subtype of Aggressive Prostate Cancer
- AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer
- Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response
- AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
- Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue
- AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer
Expo
ADLM
- Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers
- Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis
- New Machine-Learning Equation Improves LDL Cholesterol Assessment
- Blood Biomarker May Signal Cognitive Decline Risk a Decade Before Symptoms
- Ultrasensitive Biosensor Detects Early Liver Fibrosis from Blood
- Blood Gene Expression Fluctuates More Than Expected Over Time
- Genomic Test Helps Early Breast Cancer Patients Avoid Chemotherapy
- Residual Disease Test Predicts Merkel Cell Carcinoma Recurrence Earlier Than Antibody Assay
- Portable Rapid Test Aims to Detect Ebola at Point of Care
- Point-of-Care Molecular Technology Promises Transformative Shift in Oncology
- New Marker Helps Detect Aggressive Multiple Myeloma Earlier
- New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
- AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
- Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
- Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
- New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
- Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis
- Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19
- Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance
- New Rapid Ebola Antigen Test Detects Infection at Point of Care
- Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
- Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
- Bacterial Growth Assay Predicts COVID-19 Severity From Plasma
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
- Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
- Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
- Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
- Seed Amplification Test Expands Access to Neurodegenerative Disease Testing
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk
- Immune Biomarkers Support Early Risk Stratification in Oral Precancer
- Global Genetic Map Identifies Regional Parkinson’s Variants to Support Diagnostics
- Breakthrough Genetic Map Advances Understanding of Bone Disorders
- Study Identifies Hereditary Subtype of Aggressive Prostate Cancer
- All Virtual 2020 AACC Uses Artificial Intelligence to Connect Exhibitors and Attendees
- Greiner Bio-One Showcases VACUETTE Virus Stabilization Tube for Transport and Storage of COVID-19 Swab Samples
- Stago Diagnostics Transforms Hemostasis with Innovations at AACC 2020 Virtual Event
- Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event
- Seegene Highlights High-Throughput, Single Tube 8-Plex RT-PCR Test for Flu A, Flu B, RSV and COVID-19 with Dual Internal Controls
- New Test that Measures Antibodies in Girls Who Have Received HPV Vaccine Presented at AACC 2021
- Novel Insights on COVID-19 Vaccines and Virus Evolution, AI in the Clinic, and Miniaturization of Diagnostic Platforms Explored at AACC 2021
- Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021
- Group K Diagnostics Demonstrates KromaHealth Kit that Enables Lab-Quality Results at Point-of-Care
- Fluxergy Introduces First-of-Its-Kind Multi-Modal Laboratory Platform That Diagnoses COVID-19 On-Site in 60 Minutes
- Faster Method Diagnoses Pediatric Urinary Tract Infections
- Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022
- Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022
- Advanced Instruments Introduces New Automated Osmometer at AACC 2022
- Innovative Smartphone and AI-Based Tests Featured at AACC 2022
- Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023
- Laboratory Experts Show How They Are Leading the Way on Global Trends
- Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors
- Best Approach to Infectious Disease Serology Testing for Laboratorians and Clinicians Discussed at AACC 2023
- Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections
- Cytovale Demonstrates 8-Minute Sepsis Diagnostic Test
- EKF Diagnostics Showcases Range of Diabetes and Hematology POC Devices
- Inpeco Launches Next-Generation Total Lab Automation System
- Tianlong Showcases Latest Products in Molecular Diagnostics, Biochemistry, Immunology and POC Testing
- Messe Düsseldorf Promotes International “MEDICAlliance” Portfolio at ADLM 2024
- Breaking Research to Make Testing for Gynecologic Cancers More Equitable and Accurate
- Clinical Data on New Assay Panel Demonstrates Accurate Assessment of Pancreatic Cancer Risk
- AI-Powered Lyme Disease Diagnostic Test Debuts at ADLM 2025
- New Study Reveals Rapid Sepsis Test Drives 56% Boost in ED Discharges
- First-Ever Fingerstick Host-Response Test Rapidly Differentiates Between Bacterial and Viral Infections
- Cepheid Unveils Third-Generation GeneXpert System at ADLM 2026
- Ozelle Presents AI-Powered O-Cyte 1 Hematology Analyzer at ADLM 2026
- bioMérieux Showcases Latest Diagnostic Innovations at ADLM 2026
- ADLM 2026 Explores Diabetes Milestones, Space Diagnostics, Alzheimer’s–Down Syndrome Links, and Cancer Advances
- Bringing laboratory diagnostics to space
- AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer
- Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response
- AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
- Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue
- AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer
Client Login